Log In
BCIQ
Print this Print this
 

Huperzine A (INS001)

  Manage Alerts
Collapse Summary General Information
Company Insero Health Inc.
DescriptionNMDA receptor antagonist and acetylcholinesterace (AChE) inhibitor
Molecular Target NMDA receptor ; Acetylcholinesterase (AChE)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationEpilepsy
Indication DetailsTreat drug-resistant epilepsy; Treat epilepsy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/05/2015

Undisclosed

Undisclosed

Undisclosed

02/02/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today